Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
Prostate International|May 5, 2022
Clinical use of expanded prostate cancer index composite-based health-related quality of life outcomes after robot-assisted radical prostatectomy for localized prostate cancerKazuhiro Fukuda, Satoru Muto, Toshiyuki China, et al.Journal of Clinical Medicine|October 29, 2025
Renal Functional Outcomes in Robot-Assisted Partial Nephrectomy with Minimum Layer Resection Using Virtual Three-Dimensional Image AssistanceShuji Isotani, Tomoki Kimura, Taiki Ogasa, et al.Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 11, 2007
Magnetic resonance evaluation of the associations of thoracic and abdominal aortic plaques with the presence and extent of coronary artery stenosisKazuhiro Ashida, Yukihiko Momiyama, Zahi A Fayad, et al.Frontiers in Immunology|June 18, 2024
Increased circulating polymorphonuclear myeloid-derived suppressor cells are associated with prognosis of metastatic castration-resistant prostate cancerTakuro Kobayashi, Masayoshi Nagata, Tsuyoshi Hachiya, et al.European Urology Open Science|August 2, 2021
The Use of Urine <i>Mycobacterium tuberculosis</i> Complex Polymerase Chain Reaction as a Predictive Factor for Recurrence and Progression After Intravesical Bacillus Calmette-Guérin Therapy in Patients with Non-muscle‑invasive Bladder CancerSatoru Muto, Yan Lu, Hisamitsu Ide, et al.American Heart Journal|June 25, 2004
In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiographyHiroaki Taniguchi, Yukihiko Momiyama, Zahi A Fayad, et al.Plos One|January 28, 2020
Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancerNaoya Nagaya, Masayoshi Nagata, Yan Lu, et al.Scientific Reports|May 29, 2023
Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastasesHisashi Hirano, Masayoshi Nagata, Naoya Nagaya, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 25, 2013
[A case of renal carcinoid with local recurrence and multiple lymph node metastases 4 years after partial nephrectomy]Yoshimitsu Komemushi, Masayoshi Nagata, Hiroaki Nishimatsu, et al.Prostate Cancer and Prostatic Diseases|April 14, 2022
Gut environment changes due to androgen deprivation therapy in patients with prostate cancerAkimasa Kure, Tomoya Tsukimi, Chiharu Ishii, et al.Pageof 8